Marker for pancreatic non-functional neuro-endocrine tumor is
**Core Concept**
The question is testing the ability to identify a specific marker or biomarker associated with pancreatic non-functional neuro-endocrine tumors (NFNETs). NFNETs are a type of pancreatic tumor that lacks significant hormonal secretion, making it challenging to diagnose based on clinical symptoms alone. These tumors can be malignant and require specific markers for early detection and diagnosis.
**Why the Correct Answer is Right**
The correct marker for pancreatic NFNETs is Chromogranin A (CgA). CgA is a protein that is produced by neuroendocrine cells and is commonly elevated in patients with NFNETs. Elevated levels of CgA can be an indicator of tumor burden and can be used as a prognostic marker to monitor the effectiveness of treatment. CgA can be measured in the blood and is a useful marker for diagnosing and managing NFNETs.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a marker for NFNETs. While calcitonin is a marker for medullary thyroid carcinoma, it is not specific for NFNETs.
**Option B:** This option is incorrect because CA 19-9 is a tumor marker for pancreatic adenocarcinoma, not NFNETs.
**Option C:** This option is incorrect because gastrin is a marker for gastrinomas, which are a type of functional pancreatic neuroendocrine tumor.
**Clinical Pearl / High-Yield Fact**
It's essential to note that while Chromogranin A is a useful marker for NFNETs, it can also be elevated in other conditions such as atrophic gastritis, chronic kidney disease, and certain medications. Therefore, a diagnosis based on CgA levels alone should be confirmed with imaging studies and histopathological examination.
**Correct Answer: C. Chromogranin A (CgA)**